Bloomsbury Genetic Therapies

Provider of gene therapy commercialization services

placeCambridge, England, United Kingdom calendar_todayFounded 2021 groups4 employees language bloomsburygtx.com

Registered entities

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace active. Cited 65 times.

YearFilings
20241

Investor mix

6 investors on record; lead investors include UCL Technology Fund.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%
Coming soon